About HTAi
Committees & Working Groups

Interest Groups Steering Committee

Chair:

  • TBD

Members:

  • Rosmin Esmail, Disinvestment and Early Awareness, Chair (Canada)
  • Antonio Migliore, Disinvestment and Early Awareness, Co-Chair (Italy)
  • Denny John, Early Career Network, Co-Chair (India)
  • Maoling Wei, Early Career Network,Co-Chair (China)
  • Ken Bond, Ethics and HTA, Chair (Canada)
  • Dario Sacchini, Ethics and HTA, Co-Chair (Italy)
  • Jani Mueller, HTA in Developing Countries, Chair (South Africa)
  • Rabia Kahveci, Medical Devices, Chair (Turkey)
  • Richard Charter, Medical Devices, Co-Chair (Switzerland)
  • Americo Cicchetti, Hospital-based HTA, Co-Chair (Italy)
  • Marco Marchetti, Hospital-based HTA, Co-Chair (Italy)
  • Maarten Postma, Public Health, Chair (Netherlands)
  • Siw Waffenschmidt, Information Retrieval Group,  Chair (Germany)
  • Ingrid Harboe, Information Retrieval Group, Co-Chair (Norway)
  • Ann Single,  Patient and Citizen Involvement, Chair (Australia)
  • Valentina Strammielllo, Patient and Citizen Involvement, Co-Chair (Brussels)
  • Massoud Toussi, Regulatory Interactions & Conditional Coverage, Chair (France)
  • Elena Petelos, Regulatory Interactions & Conditional Coverage, Co-Chair (Greece)
  • Dimitra Lingri, Regulatory Interactions & Conditional Coverage, Co-Chair (Greece)

Observers:

  • Daniel Lalonde, HTAi Executive Director (Canada)
  • Rebecca Trowman, HTAi Director of Scientific Content (Australia)
  • Rebecca Stiffell,  HTAi Coordinator – Scientific and Health Policy Initiatives (Canada)

Terms of Reference

  • Chair: HTAi Vice President, or the immediate Past President if the Vice Presidency is vacant or the Vice President is unable to fill this role
  • Members: At least two members of HTAi, excluding the Chair; members should be board members or current leaders/representatives of existing Interest Groups and should be familiar with IG structures and governance, nominated by the Chair, Board of Directors, or Executive Committee and ratified by the Board of Directors.
  • Term of Appointment: Two years, except for the Chair whose term shall coincide with his/her term as Vice President
  • Frequency of Meetings: Quarterly or at the call of the Chair

Responsibility/Authority:

The Committee’s mandate is to make recommendations to the Board of Directors concerning issues related to IG governance and funding and to act as a liaison between IGs and the Board. Issues within the scope of the Committee’s mandate include making recommendations to the Board of Directors concerning issues related to IG governance and funding, and acting as a liaison between the IGs and the Board.